Below are the most recent publications written about "Opioid-Related Disorders" by people in Profiles.
-
Ward MK, Jafry A, Coleman S, Fernandez SB, Gwanzura T, Wagner EF. Barriers to Recovery from Opioid Use Disorder Reported by Women During 2020: Insights for the Next Public Health Emergency. Int J Environ Res Public Health. 2026 Mar 23; 23(3).
-
Carlin VE, Lape EC, Deyo AG, Ripley GH, Polhill SE, Zale EL, Nam JK, Zvolensky MJ, Maisto SA, Ditre JW. Discrimination, depressive symptoms, and prescription opioid misuse among adults with chronic pain who engage in hazardous drinking. Am J Drug Alcohol Abuse. 2026; 52(1):87-97.
-
Heredia-Negr?n F, Nagamatsu ST, Carrasquillo-Carrion K, Hurd Y, Rompala G, Mel?n K, Garcia-Vassallo G, Roche-Lima A, Montalvo-Ortiz JL. Building epigenetic risk scores of opioid use disorder: Insights from human postmortem brain data. Transl Psychiatry. 2026 Jan 09; 16(1):62.
-
Odom GJ, Brandt L, Marker A, Giorgi S, Jainarain G, Schwartz HA, Au L, Castro C. From Clinical Trials to Real-World Impact: Introducing a Computational Framework to Detect Endpoint Bias in Opioid Use Disorder Research. Drug Alcohol Rev. 2026 01; 45(1):e70085.
-
Balise RR, Grealis K, Brandt L, Luo SX, Odom G, Jean-Baptiste G, Feaster DJ. Applying machine learning in predicting medication treatment outcomes for opioid use disorder. J Subst Use Addict Treat. 2026 Mar; 182:209847.
-
Syvertsen J, Cabral A, Knaap E, Rey S, Pollini RA. The emergence of fentanyl in a stimulant landscape: Un/intentional use, social relations, and developing communities of care. Int J Drug Policy. 2025 Jun; 140:104807.
-
Tata V, Varisco TJ, Rinker DV, Abughosh S, Rhodes C, Thornton JD. Concurrent Depression Management in Patients with Opioid Use Disorder Undergoing Buprenorphine Therapy: Association with Buprenorphine Discontinuation. J Dual Diagn. 2025 Apr; 21(2):142-151.
-
Lovett K, Zatzick D, Palinkas LA, Engstrom A, Nye E, Field C, McGovern M, Parrish C, Banta-Green CJ, Whiteside LK. Adapting to the Fentanyl Epidemic: Rapid Qualitative Observations and Derived Clinical and Research Implications from the Emergency Department Longitudinal Integrated Care (ED-LINC) Randomized Clinical Trial. Psychiatry. 2025; 88(4):333-350.
-
Iscoe MS, Diniz Hooper C, Levy DR, Buchanan L, Dziura J, Meeker D, Taylor RA, D'Onofrio G, Oladele C, Sarpong DF, Paek H, Wilson FP, Heagerty PJ, Delgado MK, Hoppe J, Melnick ER. Adaptive decision support for addiction treatment to implement initiation of buprenorphine for opioid use disorder in the emergency department: protocol for the ADAPT Multiphase Optimization Strategy trial. BMJ Open. 2025 Feb 20; 15(2):e098072.
-
Ovalles Lacruz A, Valle MS, Santoyo K, Clarke RD, Bhoite P, Alarcon LN. Empowering Future Physicians: Enhancing Naloxone Competency Through Early Harm Reduction Training in Medical Education. MedEdPORTAL. 2025; 21:11499.